RFI

MENU

Szukaj

    RFI

    Drop in a message and we will reach out to you

    Support and brokerage in product portfolio optimization

    Acquisition of new products in the pharmaceutical industry – the most popular business models

    The pharmaceutical sector is one of the most innovative, competitive and globalized business area. Especially in such a developed and interconnected market as the European Union where Competitors often operate in multiple national markets simultaneously. In order to adapt to a changing business environment, pharmaceutical companies must constantly look for new business opportunities and improve strategies to optimize their products portfolio.

    Instead of developing a new pharmaceutical product themselves, it is often more efficient to acquire a product with Marketing Authorisation from a third party. This strategy is known as in-licensing and usually refers to the purchase of product dossier rights or a Marketing Authorization along with the supply of the finished product. Other modifications are also used in business practice. If you are interested in a product licensing, it is extremely important to do research the market and find potential trustworthy partners offering MA or dossier for purchase, as well as product supply.

    Another key aspect during business negotiations is the audit of a product dossier in terms of legal requirements. Failure to meet the requirements, may significantly delay or even hold a product launch to the market. Therefore, it is extremely important to verify a potential business partner and a product before signing the final contracts. For this purpose, many companies outsource all or part of the tasks related to the purchase of a new product to specialized consulting companies with experience in this field.

    Trust the experts

    As the experienced consulting company, providing comprehensive services for the pharmaceutical sector, Sciencepharma has helped many pharmaceutical companies with the purchase of products (via support in MAH transfer) and/or dossiers. We do have a network of contacts, both inside and outside the EU, to quickly help you find and purchase new products or dossiers. Moreover our experienced experts are able to effectively evaluate pharmaceutical products or medical devices and their documentations and identify potentially sensitive issues affecting the market launch.

    Cooperation benefits

    • Quick and effective searching the market for the products you are interested in, due to our wide network of contacts,
    • List of products or dossiers to be purchased, together with contact to persons responsible at the tenderer and a detailed report on carried out activities,
    • Collecting objective commercial offers without revealing your company name in preliminary discussions with a potential partner,
    • Support from a panel of experienced experts who can efficiently evaluate the product and its dossier,
    • Support in business negotiations,
    • In case of new registration, support in the registration procedure,
    • In case of MAH transfer, support in the procedure,
    • Support in Post-authorisation activities and Pharmacovigilance.

    Do not hesitate to contact us. We will be happy to support you in your market success and answer all your questions.

    How can we help You?

      Please be advised that the administrator of personal data entered in the above form is SciencePharma Sp. z o.o. with its registered office in Warsaw, Chełmska 30/34. These data are processed in order to receive incoming correspondence and respond to it. Providing personal data is voluntary, but necessary to send the form. Each person has the right to access their data and correct it.

      You can read the details on the protection of personal data here.